The CEO of "BIAS", Emeritus Professor Pat Carnegie, has had many years of experience in Biotechnology, Immunology and Biochemistry. A team, whose members can be contracted to provide expertise in rapidly developing areas, assists him. "BIAS" is interested in giving technical advice in:
"BIAS" will assist in:
*periodic reviews of research projects,
*selection of appropriate staff,
*advise on suitable equipment and technology,
*help provide links to possible collaborators,
*review publications relevant to the project,
*assist with the preparation of publications,
*etc.
"BIAS" maybe able to supply staff able to give lectures and tutorials in a range of subjects at relatively short notice to assist departments.
The CEO has previously examined many theses for PhD and Masters degrees and is prepared to consider requests appropriate to his area of expertise.
"BIAS" is able to contribute to reviews of educational programs in Biotechnology
"BIAS" is able to offer brokers, bankers and investors an unbiased opinion on the technical merits of an IPO. "BIAS" will not provide any detailed assessment of the likely financial outcome of the proposal but will comment on the relevance of the technology, known competition and other approaches being proposed to satisfy the market.
For example, "BIAS" could have warned potential investors in Pi2 of risks from other companies chasing the psoriasis market. When Pi2 went from a high of 68 cents at the time of the float in August to 16 cents in November it was featured in an article in "THE BULLETIN" by Alan Deans who commented
In future get an opinion from "BIAS" before investing!
When venture capitalists and "angels" are considering an investment in a Biotechnology start-up they should obtain independent advice on the technology proposed by the company and the possibility that their strategy is flawed. "BIAS" is able to provide advice for a wide range of Biotechnology projects and where it has not the expertise it will provide a link to another consultant.
"BIAS" will review laboratory notebooks containing key intellectual property and patents. However, it will not provide opinions on the validity of patents as judging patents in Biotechnology is very complex and requires a patent attorney with appropriate experience.
"BIAS" can assist with the drafting of grant applications to State and Commonwealth government agencies and to various foundations. "BIAS" is more interested in giving technical advice and is not interested in competing with other consultants who will manage the preparation of business plans that are required by several agencies as part of the grant application.
"BIAS" is able to give advice on the structure of the program and strategies to effectively market conferences involving Biotechnology. The CEO has played a leading role in organising several successful national and international Biotechnology conferences. "BIAS" is not competing with established conference organisers but is able to provide them with unbiased advice on speakers, likely participants, and strategies to get maximum support from the general public.